IMMUNIC, INC. — Director's Dealing 2016

Aug 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2016-08-11

Reporting Person: Hasnain Faheem (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-12	Common Stock	P	118243	$5.92	Acquired	122743	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-11	Stock Option (right to buy)	$5.92	A	58574	Acquired	2026-08-10	Common Stock (58574.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3500	Indirect

Footnotes

F1: Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through each vesting date, 1/48th of the shares subject to the option shall vest and become exercisable monthly such that 100% of the shares subject to the option shall be fully vested and exercisable on August 11, 2020.